close

Singapore's Temasek buys 41% stake in Manipal Health for $2 billion: Report

Manipal currently serves over 5 million patients a year through its 29 hospitals in 16 cities with 4,000 doctors, according to a statement issued jointly by the investors

Reuters MUMBAI
Temasek

Listen to This Article

MUMBAI (Reuters) - Singapore-based sovereign wealth fund Temasek said on Monday that it is acquiring an additional 41% stake in India's Manipal Health Enterprises from investors including TPG, boosting its stake in one of the country's largest hospital chains to 59%.

While Manipal did not specify the deal value, Temasek has paid about $2 billion for the additional stake, said a person with direct knowledge of the matter. Manipal did not immediately respond to a query seeking comment.

Private equity firm TPG, an investor in Manipal since 2015, will fully exit its stake, though it will reinvest via a new fund.

India's sovereign wealth fund, the National Investment and Infrastructure Fund (NIIF), will also sell its full stake to Temasek, while Manipal founder Ranjan Pai's family holding will reduce from about 50% to 30%.

Manipal currently serves over 5 million patients a year through its 29 hospitals in 16 cities with 4,000 doctors, according to a statement issued jointly by the investors.

"By re-investing through our new Asia fund - TPG Asia VIII, we look forward to continuing to support Manipal's mission of bridging the quality healthcare infrastructure gap in the country," said Puneet Bhatia, co-managing partner of TPG Capital Asia.

Also Read

Singapore's Temasek remains invested in Adani Ports: Media report

Budget 2023 to increase capex for infra projects for growth: Experts

Women bosses fare worst in accumulated savings: Gender Wealth Equity report

More people adopting preventive healthcare post-Covid, say experts

Debt fund taxation changes to impact corporate bond demand: Fund managers

Apple signs lease for 116,000 sq ft space in Bengaluru for Rs 2.44 cr/month

Tata Group set to takeover of Wistron's iPhone plant in Bengaluru

Indian pharma market back to pre-Covid level in FY23, says report

Next Orbit to sell its entire stake in ISMC to Delhi-based B C Jindal group

LTIMindtree delays onboarding and extends training for assessment

 

(Reporting by M. Sriram in Mumbai and Kane Wu in Hong Kong; Editing by Savio D'Souza)

First Published: Apr 10 2023 | 10:05 AM IST